BRPI1012344A2 - uso de g-csf para a extensão da janela de tempo terapêutica para terapia de derrame trombolítico. - Google Patents

uso de g-csf para a extensão da janela de tempo terapêutica para terapia de derrame trombolítico.

Info

Publication number
BRPI1012344A2
BRPI1012344A2 BRPI1012344A BRPI1012344A BRPI1012344A2 BR PI1012344 A2 BRPI1012344 A2 BR PI1012344A2 BR PI1012344 A BRPI1012344 A BR PI1012344A BR PI1012344 A BRPI1012344 A BR PI1012344A BR PI1012344 A2 BRPI1012344 A2 BR PI1012344A2
Authority
BR
Brazil
Prior art keywords
csf
extension
time window
therapeutic time
stroke therapy
Prior art date
Application number
BRPI1012344A
Other languages
English (en)
Inventor
Armin Schneider
Marc Fisher
Original Assignee
Sygnis Bioscience Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sygnis Bioscience Gmbh & Co Kg filed Critical Sygnis Bioscience Gmbh & Co Kg
Publication of BRPI1012344A2 publication Critical patent/BRPI1012344A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI1012344A 2009-02-17 2010-02-17 uso de g-csf para a extensão da janela de tempo terapêutica para terapia de derrame trombolítico. BRPI1012344A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15307909P 2009-02-17 2009-02-17
PCT/US2010/024426 WO2010096446A1 (en) 2009-02-17 2010-02-17 Use of g-csf for the extension of the therapeutic time-window of thrombolytic stroke therapy

Publications (1)

Publication Number Publication Date
BRPI1012344A2 true BRPI1012344A2 (pt) 2016-03-22

Family

ID=42634192

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1012344A BRPI1012344A2 (pt) 2009-02-17 2010-02-17 uso de g-csf para a extensão da janela de tempo terapêutica para terapia de derrame trombolítico.

Country Status (9)

Country Link
US (1) US20120070403A1 (pt)
EP (1) EP2398493A1 (pt)
JP (1) JP2012518014A (pt)
CN (1) CN102316891A (pt)
AU (1) AU2010216083A1 (pt)
BR (1) BRPI1012344A2 (pt)
CA (1) CA2751032A1 (pt)
RU (1) RU2011138165A (pt)
WO (1) WO2010096446A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
US9333233B2 (en) * 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
CN107427255B (zh) * 2015-03-12 2021-04-06 财团法人峨山社会福祉财团 基于脑图像而估算梗塞区域的发生时点的方法
AU2018348138A1 (en) * 2017-10-11 2020-04-23 Ambrx, Inc. Porcine G-CSF variants and their uses
CN110288587A (zh) * 2019-06-28 2019-09-27 重庆同仁至诚智慧医疗科技股份有限公司 一种缺血性脑卒中磁共振影像的病灶识别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785601B2 (en) * 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors

Also Published As

Publication number Publication date
CA2751032A1 (en) 2010-08-26
EP2398493A1 (en) 2011-12-28
CN102316891A (zh) 2012-01-11
JP2012518014A (ja) 2012-08-09
US20120070403A1 (en) 2012-03-22
WO2010096446A1 (en) 2010-08-26
AU2010216083A1 (en) 2011-08-18
RU2011138165A (ru) 2013-03-27

Similar Documents

Publication Publication Date Title
LTPA2018001I1 (lt) Suderinta terapija, skirta LOPL
BRPI1008955A2 (pt) Terapia de combinação com derivados de tiocolchicina.
ATE526024T1 (de) Fluvoxamin vermeidende pirfenidontheraphy
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
BRPI1006438A2 (pt) terapia adjuvante de cancer
BR112014028755A2 (pt) composição de argamassa de poliuretano, processo para preparação da composição de argamassa de poliuretano, e, uso de uma composição de argamassa de poliuretano.
BRPI0912420A2 (pt) portal wlan sequenciável
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
DK3018116T3 (da) Vitamin k2-intermediater
BRPI0911577A2 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
IT1396935B1 (it) Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
BR112013033974A2 (pt) terapia de combinação
BRPI0821248A2 (pt) Inibidores de cinesina como fármacos terapêuticos para câncer
BRPI1007995A2 (pt) orto-aminoamidas para o tratamento de cãncer.
BRPI0910534A2 (pt) terapia antiviral
ES2714390T8 (es) Aplicador de terapia con ultrasonidos
FR2973218B1 (fr) Plaque d'osteosynthese.
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
BRPI0812040A2 (pt) Indicações para terapia de anti-il-i-beta
FI20106240A0 (fi) Lähetinvastaanotinyksikkö
BR112014002830A2 (pt) fotossensibilizador para uso terapêutico
BRPI0920743A2 (pt) ribonucleases terapeuticas
BRPI0922367A2 (pt) enzastaurin para o tratamento de câncer
BRPI1009448A2 (pt) combinações farmacêuticas compreendendo edea119/bay 869766 para o tratamento de cânceres específicos

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.